Charlie Rose Science Series Episode #7 - July 24, 2007
Charlie Rose Science Series Episode #7 - July 24, 2007
Panel to Discuss HIV/AIDS, Trends, Major Breakthroughs, Treatment and Prevention Programs WHAT: The upcoming episode of the Charlie Rose Science Series will focus on HIV/AIDS, its continued growth as a worldwide epidemic, and efforts to educate, protect, and treat people around the globe. A panel of leading experts will address factors which contribute to high infection rates, current treatment and prevention strategies, and new medical breakthroughs in fighting HIV/AIDS. WHO: Guests will include: - Seth Berkley, MD, President and Founder of the International AIDS Vaccine Initiative (IAVI) - Scott Hammer, MD, Chief of the Division of Infectious Diseases at the Columbia Presbyterian Medical Center - Peter Kwong, PhD, Chief of Structural Biology Section, Vaccine Research Center at the National Institutes of Health (NIH) - Judy Lieberman, MD, PhD, Director, Division of AIDS at Harvard Medical School and Senior Investigator, The CBR Institute for Biomedical Research WHEN: Begins Airing on July 24, 2007 on PBS stations. Check your local PBS listings for show times. DESCRIPTION:
The Charlie Rose Science Series sponsored by Pfizer Inc is an exploration of modern advances in scientific research, their contribution to our understanding of the world around us, and how science breakthroughs can be applied to improving human health.
Charlie Rose is joined in this effort by his co-host, Sir Paul Nurse, PhD, Nobel Laureate and President of Rockefeller University.
As a world leader in research and development, Pfizer is committed to increasing public understanding of science and science education. For more information about The Charlie Rose Science Series or to watch clips from past episodes, please visit http://www.charlierose.com/.
CONTACT: Rexy Legaspi of Widmeyer Communications, +1-646-213-7245.
PRNewswire -- July 20
First Call Analyst:
FCMN Contact:
Source: Pfizer Inc
CONTACT:
Web site: http://www.charlierose.com/
Profile: International Entertainment
0 Comments:
Post a Comment
<< Home